Form 4: Bentley Systems CEO Nicholas Cumins Acquires Additional Shares Through Dividend Equivalent Rights
SEC Form 4 Filing
Nicholas Cumins, CEO of Bentley Systems, acquired 386 shares of Class B Common Stock on September 26, 2024, through dividend equivalent rights.
Summary
- On September 26, 2024, Nicholas Cumins, the CEO of Bentley Systems, acquired 386 shares of Class B Common Stock.
- The acquisition was a result of dividend equivalent rights accruing to Cumins in connection with dividends paid by Bentley Systems on previously granted awards.
- The price per share for this acquisition was $0.00.
- Following the transaction, Cumins directly owns 381,157 shares of Class B Common Stock.
- The transaction was reported on September 30, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it reflects a routine transaction related to executive compensation. It doesn't indicate any significant positive or negative development for the company.
Positives
- The acquisition of shares by the CEO through dividend equivalent rights could be seen as a positive sign, indicating confidence in the company's performance and future prospects.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it primarily reflects an adjustment to the CEO's stock ownership related to dividend payments.
Key Dates
| Date | Description |
|---|---|
| 09/26/2024 | Date of transaction: Nicholas Cumins acquired 386 shares of Class B Common Stock. |
| 09/30/2024 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.